Sign in
Active, not recruitingNo phase

Comprehensive Long-term Follow up of Adults With Arterial Switch Operation

Key facts

Who runs it
University of Zurich
Where
Austria, France, Netherlands, Spain, and Switzerland11 sites in 5 countriesChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
540 people enrolled
Started
1 Oct 2019
Expected to end
30 Sept 2039
Type of study
Observational
Treatments tested
  • No intervention is planed
Record updated
8 November 2022

Who can take part

Age
16 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Adults (≥16 years)
  • with transposition of great arteries or a Taussig-Bing anomaly
  • who underwent repair by an ASO, and who are actively followed at one of the participating centers will be enrolled

Who cannot take part

  • Incapability of giving informed consent and previous heart transplant

This trial has no sites in United States.

It has sites in 5 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Background: Long-term outcomes in adults with prior arterial switch operation (ASO) have not yet been well defined. The aim of this study is to elucidate incidence and predictors of adverse cardiac outcomes in a prospectively followed cohort of adults after their ASO.

Read full original descriptionShow less

Methods: The comprehensive long-term follow up of adults with ASO is a project within the European collaboration for prospective outcome research in congenital heart disease (EPOCH). It is designed as a prospective, international multicenter cohort study. Consecutive patients (aged 16 years or more) with prior ASO will be included at 11 European tertiary care centers. Participants will be followed according to a standardized protocol following international recommendations, including standardized protocols for imaging and for exercise testing. Main outcome measures are all-cause and cardiac-related mortality, rate of cardiac re-intervention, neo-aortic dissection, myocardial infarction, stroke, infective endocarditis, sustained atrial and ventricular arrhythmias, new-onset or worsening pulmonary hypertension and new-onset heart failure. Secondary endpoints are frequency and progression of right ventricular outflow tract stenosis, neo-aortic root dilatation, neo-aortic valve regurgitation and ventricular dysfunction. The impact of demographic, anatomic (e.g. coronary artery anatomy) and functional variables on the above-mentioned outcomes, as well as quality of life and incidence of pregnancy related complications will also be assessed.

Aim: The prospective, international, multicenter EPOCH-ASO study will provide a better understanding of adverse outcomes and their predictors in adults after ASO. The results of the EPOCH-ASO study may help to optimize future care of this novel patient cohort in adult cardiology.

The group in the trial

  • Arterial Switch Operation - Transposition of Great Arteries

    Patients with previous arterial switch operation for the treatment of a transposition of great arteries will constitute the sole group of the cohort.

    Treatment: No intervention is planed

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comprehensive Long-term Follow up of Adults With Arterial Switch Operation - European Collaboration for Prospective Outcome Research in Congenital Heart Disease
Publications
Record updated
8 November 2022